» Articles » PMID: 2452184

Picogram Quantities of Anti-Ig Antibodies Coupled to Dextran Induce B Cell Proliferation

Overview
Journal J Immunol
Date 1988 May 15
PMID 2452184
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the properties which enable type 2 Ag, as exemplified by dextran and Ficoll, to stimulate high levels of antibody responses in the relative absence of T cells, we conjugated anti-IgD and anti-IgM mAb to both dextran and Ficoll and examined their B cell-activating properties. Such conjugated anti-Ig antibodies stimulated both early and later stages of B cell activation at picogram concentrations, which are at least 1000-fold lower than that required for B cell stimulation by unconjugated anti-Ig antibodies, and the level of proliferation they stimulated was on average 10-fold greater. Furthermore, concentrations of anti-Ig dextran (100 pg/ml) which modulated little sIgD from the B cell surface were strong inducers of enhanced B cell expression of MHC class II molecules. Conjugation of Fab fragments of anti-IgD or nonmitogenic anti-IgM mAb to dextran rendered them as mitogenic as dextran conjugated to strongly stimulatory anti-IgD or anti-IgM antibodies. The ability of dextran and Ficoll to serve as effective carrier molecules for anti-IgD was not related solely to their large m.w., because anti-IgD coupled to polymerized BSA (m.w. 1.5 X 10(6), was only 10- to 50-fold more potent than unconjugated anti-IgD antibodies at stimulating B cell DNA synthesis. These results suggest, therefore, that the unique ability of picogram concentrations of haptenated type 2 Ag to stimulate Ig secretion in the absence of T cells may be a function of their ability to promote effective cross-linking without resulting in the modulation of sIg. This would enable such Ag to mediate repetitive B cell signaling, a situation that cannot be achieved by unconjugated anti-Ig antibodies which result in modulation of sIg at their mitogenic concentrations. These compounds therefore may be employed to study B cell activation stimulated by sIg cross-linking at concentrations that may more closely reflect those which are achieved under physiologic conditions by type 2 Ag.

Citing Articles

Enhanced B Cell Receptor Signaling Partially Compensates for Impaired Toll-like Receptor 4 Responses in LPS-Stimulated IκBNS-Deficient B Cells.

Adori M, Khoenkhoen S, Zhang J, Dopico X, Karlsson Hedestam G Cells. 2023; 12(9).

PMID: 37174629 PMC: 10177494. DOI: 10.3390/cells12091229.


Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class Switching.

Pone E, Hernandez-Davies J, Jan S, Silzel E, Felgner P, Davies D Front Immunol. 2022; 13:882502.

PMID: 35663959 PMC: 9161726. DOI: 10.3389/fimmu.2022.882502.


Protocol for BCR-mediated plasma cell differentiation and purification of chromatin-associated proteins.

Ochiai K, Shima H, Ikura T, Franke M, Sievert E, Sciammas R STAR Protoc. 2021; 2(3):100633.

PMID: 34258594 PMC: 8255920. DOI: 10.1016/j.xpro.2021.100633.


Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.

Leon M, Wemlinger S, Larson N, Ruffalo J, Sestak J, Middaugh C Mol Pharm. 2019; 16(4):1563-1572.

PMID: 30681867 PMC: 7446942. DOI: 10.1021/acs.molpharmaceut.8b01250.


Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

ORourke J, Peabody D, Chackerian B Curr Opin Virol. 2015; 11:76-82.

PMID: 25829254 PMC: 4456241. DOI: 10.1016/j.coviro.2015.03.005.